Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CareDx (CDNA)
NASDAQ:CDNA
CareDx (CDNA) Stock Price & Analysis
708 Followers
CDNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.80 - $19.58
Previous Close$18.87
Volume527.82K
Average Volume (3M)822.61K
Market Cap
$967.72M
Enterprise Value$793.79M
Total Cash (Recent Filing)$215.92M
Total Debt (Recent Filing)$26.89M
Price to Earnings (P/E)―
Beta1.70
Next Earnings
Jul 31, 2024EPS Estimate
-$0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.43
Shares Outstanding52,083,792
10 Day Avg. Volume968,481
30 Day Avg. Volume822,610
Standard Deviation0.22
R-Squared0.18
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)4.18
Price to Sales (P/S)11.17
Price to Cash Flow (P/CF)-21.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.89
Enterprise Value/Gross Profit4.45
Enterprise Value/Ebitda-11.05
Forecast
1Y Price Target
$17.00Price Target Upside-8.50% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering6
CareDx News
Bulls Say, Bears Say
Bulls Say
Clinical OutcomesThe SHORE study observed excellent clinical outcomes in patients managed with HeartCare, including 95% survival and 97% with normal allograft function at two years post-transplantation.
Market AdoptionData from the SHORE study could help drive further market adoption of HeartCare.
Revenue GuidanceAll segments of businesses exhibited healthy performance in 1Q24, management has raised the 2024 revenue guidance to $274-282M from $260-274M.
Bears Say
Financial PerformanceNet loss was $16.7M, or ($0.32) per share.
Judicial ReviewCDNA continues to seek judicial review of the $96M that a jury awarded to Natera from CDNA, and any final damages amount could take ~2 years to determine.
Legal IssuesCareDx is seeking to invalidate the '544 patent on the same grounds as the '724 patent, which was dismissed as invalid or patent ineligible.
---
Ownership Overview
18.88% Insiders
28.03% Mutual Funds
44.30% Other Institutional Investors
8.78% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CDNA FAQ
What was CareDx’s price range in the past 12 months?
CareDx lowest stock price was $4.80 and its highest was $19.58 in the past 12 months.
What is CareDx’s market cap?
Currently, no data Available
When is CareDx’s upcoming earnings report date?
CareDx’s upcoming earnings report date is Jul 31, 2024 which is in 5 days.
How were CareDx’s earnings last quarter?
CareDx released its earnings results on May 09, 2024. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.474 by $0.154.
Is CareDx overvalued?
According to Wall Street analysts CareDx’s price is currently Overvalued.
Does CareDx pay dividends?
CareDx does not currently pay dividends.
What is CareDx’s EPS estimate?
CareDx’s EPS estimate is -$0.4.
How many shares outstanding does CareDx have?
CareDx has 52,083,794 shares outstanding.
What happened to CareDx’s price movement after its last earnings report?
CareDx reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.474. Following the earnings report the stock price went up 34.087%.
Which hedge fund is a major shareholder of CareDx?
Among the largest hedge funds holding CareDx’s share is ARK Investment Management LLC. It holds CareDx’s shares valued at 62M.
---
CareDx Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.00 (-8.50% Downside)
$17.00 (-8.50% Downside)
Blogger Sentiment
Neutral
CDNA Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.7%
Last 30 Days ▲ 11.9%
Last 30 Days ▲ 11.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
71.38%
12-Months-Change
Fundamentals
Return on Equity
-54.18%
Trailing 12-Months
Asset Growth
-14.35%
Trailing 12-Months
Company Description
CareDx
CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
---
CDNA Earnings Call
Q1 2024
0:00 / 0:00
---
CDNA Stock 12 Month Forecast
Average Price Target
$17.00
▼(-8.50% Downside)
Technical Analysis
Best Analysts Covering CDNA
1 Year
1 Year Success Rate
3/5 ratings generated profit
1 Year Average Return
+38.20%
reiterated a buy rating 2 months ago
Copying Mason Carrico's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +38.20% per trade.
---